CervoMed Inc. share price logo

CervoMed Inc.

NASDAQ: CRVO

Small Cap

$3.89

-0.35

(-8.25%)

Live

as on

CervoMed Inc. Stock Performance

as on June 23, 2026 at 1:09 am IST

  • Day's Low

    Day's High

    $3.83
    $4.10
    downward going graph

    1.54%

    Downside

    5.40%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $2.13
    $13.13
    downward going graph

    45.24%

    Downside

    237.53%

    Upside

    downward going graph

CervoMed Inc. share price movements today

Previous Close
$4.24
Open
$4.03
Volume
507.5K
Day's Low - High
$3.83 - $4.10
52 Week Low - High
$2.13 - $13.13

CervoMed Inc. Historical Returns

1 Month Return
+ 38.56 %
3 Month Return
+ 5.47 %
1 Year Return
-38.1 %
3 Year Return
0 %
5 Year Return
0 %

CervoMed Inc. Stock Fundamentals & Key Indicators

Check CervoMed Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$39.3M

EPS (TTM)

-2.6767

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-

Revenue (TTM)

2.1M

Profit Margin

0.00%

Return On Equity TTM

-132.76%

CervoMed Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of CervoMed Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
CervoMed Inc. image
CervoMed Inc.
BUY$39.3MNANA0.00%NA
Alnylam Pharmaceuticals Inc. image
Alnylam Pharmaceuticals Inc.
BUY$37.1B60.79%69.8712.55%NA
Vertex Pharmaceuticals Inc. image
Vertex Pharmaceuticals Inc.
BUY$114.6B139.12%26.835.51%NA
Regeneron Pharmaceuticals Inc. image
Regeneron Pharmaceuticals Inc.
BUY$63.9B14.22%14.8829.65%0.59%

Stock Returns calculator for CervoMed Inc. Stock including INR - Dollar returns

The CervoMed Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

CervoMed Inc. investment value today

Current value as on today

₹62,101

Returns

-₹37,899

(-37.9%)

Returns from CervoMed Inc. Stock

-₹43,212 (-43.21%)

Dollar Impact

₹5,313 (+5.31%)

Analyst Recommendation on CervoMed Inc. Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for CervoMed Inc.. Average target price of $19.5

CervoMed Inc. Share Price Target

Get share price movements and forecasts by analysts on CervoMed Inc..

What analysts predicted

80.05%UPSIDE

Target Price

$19.5

Current Price

$3.89

Analyzed by

7 Analysts

Target

$19.50

CervoMed Inc. target price $19.5, a slight upside of 80.05% compared to current price of $3.89. According to 7 analysts rating.

Indian Investors' Interest in CervoMed Inc. Stock

Investment in CervoMed Inc. Shares on INDmoney has grown by 4000.00% in the last 30 days, indicating increased investment activity.

Time period: to

Change:4000.00% versus previous 30 day period

Search interest for CervoMed Inc. Stock has increased by 3225% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:3225% versus previous 30 day period

CervoMed Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
2
2
3
1
2
1
1
0
0
-
Gross Profit
0
0
3
-3
-4
-2
-3
0
-
-
Operating Income
-2
-2
-2
-5
-7
-5
-6
-8
-8
-8
EBITDA
3
-2
-2
-4
-6
-4
-6
-7
-8
-7
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-2
-2
-2
-4
-6
-4
-6
-7
-8
-7
Income Tax Expense
0
0
0
-
-
-
-
-
-
-
Net Income
-2
-2
-2
-4
-6
-4
-6
-7
-8
-7
Net Profit Margin
-94.84%
-107.13%
-70.44%
-245.03%
-310.17%
-255.30%
-356.05%
-2395.34%
-92680.37%
0.00%

CervoMed Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
7
9
4
Gross Profit
0
0
0
-1
-1
-9
-
Operating Income
-11
-15
-24
-15
-7
-18
-28
EBITDA
-11
-15
-15
-3
-2
-16
-26
Interest Expense
-
-
-
0
-
-
-
Depreciation
0
0
0
0
-
-
-
Income Before Tax
-11
-15
-24
-15
-2
-16
-26
Income Tax Expense
0
-1
0
-3
0
-
-
Net Income
-11
-14
-24
-15
-2
-16
-26
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
-30.40%
-167.29%
-673.06%

CervoMed Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-2
-2
-4
-6
-4
-6
-7
-8
-7
Operating Cash Flow
-1
-2
-4
-8
-3
-6
-6
-6
-8
Investing Cash Flow
-
-40
2
9
5
0
7
5
7
Financing Cash Flow
-
46
0
-
-
4
-
-
0
Change in Cash
-1
3
-2
1
1
-2
1
-1
0

CervoMed Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-1
-18
-11
-14
-24
-5
-2
-16
-26
Operating Cash Flow
-12
-10
-9
-13
-14
-2
-7
-16
-23
Investing Cash Flow
0
-
-
-
0
-12
-
-28
18
Financing Cash Flow
20
9
16
17
33
0
11
46
4
Change in Cash
7
0
6
4
18
-33
3
1
0

Global Institutional Holdings in CervoMed Inc.

Funds
Holdings
UBS Group AG
0.06%
Vanguard Capital Management, LLC
3.42%
Millennium Management LLC
2.26%
Citadel Advisors Llc
0.53%
Renaissance Technologies Corp
0.69%
See all

CervoMed Inc. News & Key Events

  • img

    Today's Timeline - 18 June

    Thu, 04:30 PM

    -

    CervoMed receives patent for neflamapimod to treat dementia with Lewy bodies, protecting use until 2042.

    Thu, 10:05 PM

    -

    CervoMed announces $10 million stock offering of 2.5 million shares at $4.00 each for working capital.

    Thu, 11:25 PM

    -

    CervoMed stock surges 95% on patent news before retreating after announcing stock offering.

Insights on CervoMed Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, CRVO stock has moved up by 71.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Regeneron Pharmaceuticals, Inc. Common Stock has given 19.7% return, outperforming this stock by 57.8%

About CervoMed Inc.

CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. The company is developing neflamapimod, an orally administered small molecule drug that crosses the blood"brain barrier and inhibits the enzyme p38a. Neflamapimod has the potential to reverse synaptic dysfunction, improve neuron health, and slow or prevent disease progression. Neflamapimod is currently in clinical development for the treatment of dementia with Lewy bodies, non-fluent variant primary progressive aphasia, amyotrophic lateral sclerosis, and amyotrophic lateral sclerosis. CervoMed Inc. was founded in 2010 and is headquartered in Boston, Massachusetts.
OrganisationCervoMed Inc.
Headquarters20 Park Plaza, Boston, MA, United States, 02116
IndustryBiotechnology
CEODr. John J. Alam M.D.
E-voting on sharesClick here to vote

Key Management of CervoMed Inc.

Name

Title

Dr. Marinus Verwijs Ph.D.

Executive Vice President of Technical Operations

Dr. Mark A. De Rosch Ph.D.

Executive VP of Regulatory, Government Affairs & Program Management

Dr. Claudia Ordonez M.D.

Senior Vice President of Medical Science

Dr. Matthew Winton Ph.D.

Chief Commercial & Business Officer

Dr. John J. Alam M.D.

Co-Founder, CEO, President & Director

Dr. Sylvie L. Gregoire Pharm.D.

Co-Founder & Director

Mr. William Robert Elder J.D.

CFO, General Counsel & Corporate Secretary

Ms. Kelly Blackburn M.H.A.

Executive Vice President of Clinical Development

FAQs

What is CervoMed Inc. share price today?

CervoMed Inc. share price today is $3.89 as on . CervoMed Inc. share today touched a day high of $4.1 and a low of $3.83.

What is the 52 week high and 52 week low for CervoMed Inc. share?

CervoMed Inc. share touched a 52 week high of $13.13 on and a 52 week low of $2.13 on . CervoMed Inc. stock price today i.e. is trending at $3.89,which is 70.37% down from its 52 week high and 82.63% up from its 52 week low.

What is CervoMed Inc.'s market capitalisation today?

CervoMed Inc. market capitalisation is $0.00T as on .

How to invest in CervoMed Inc. Stock (CRVO) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for CervoMed Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in CervoMed Inc. Shares that will get you 0.3856 shares as per CervoMed Inc. share price of $3.89 per share as on June 22, 2026 at 7:39 pm IST.

What is the minimum amount required to buy CervoMed Inc. Stock (CRVO) from India?

Indian investors can start investing in CervoMed Inc. (CRVO) shares with as little as ₹94.68 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹946.80 in CervoMed Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on CervoMed Inc. share’s latest price of $3.89 as on June 22, 2026 at 7:39 pm IST, you will get 2.5707 shares of CervoMed Inc.. Learn more about fractional shares .